News & Press

CordenPharma Completes Executive Team with CQCO & COO

May 4, 2020
News > CordenPharma Completes Executive Leadership Team with CQCO & COO

CordenPharma Completes Executive Leadership Team with CQCO & COO

 


CordenPharma is very pleased to announce the completion of its Executive Leadership Team with the appointments of William Cashin as Chief Quality & Compliance Officer (CQCO) effective May 4, 2020, and Dr. Lee Newton as Chief Operating Officer (COO) effective June 2, 2020.

William Cashin
Chief Quality & Compliance Officer, CordenPharma

William Cashin joins us from Lonza, where he served as Global Head Quality, Mammalian & Microbial. In this role, he was directly responsible for all aspects of quality for biopharmaceutical global manufacturing operations within Europe, North America, Singapore and China. Will worked extensively in the pharmaceutical industry, including roles of increasing responsibility at Alexion, GSK and Pfizer. He holds a Bachelor’s degree in Applied Chemistry from Waterford Institute of Technology in Ireland and a Master’s degree in Business Administration through the Open University, (UK).

Dr. Lee Newton
Chief Operating Officer, CordenPharma

Dr. Lee Newton joins us from Lonza, where he most recently held the role of Senior Vice President and Business Unit Head for Lonza’s small molecule API business. Lee has over 20 years of experience within the Pharmaceutical Industry. After beginning his career in primary manufacturing with GlaxoWellcome, Lee moved into the CDMO sector in 2002 with Avecia, and has worked in various operational and commercial roles with increasing responsibility including as Operations Director for Carbogen Amcis. He holds a PhD in organic chemistry from the University of Heriot-Watt (UK).